In brief
- The brain passes signals between cells using chemical messengers.
- Dopamine helps the brain learn to repeat behavior associated with reward.
- NIDA describes changes in circuits involved in reward, stress, and self-control.
- NIDA describes addiction as a chronic, treatable condition.
How cells pass a message
The National Institute on Drug Abuse (NIDA) describes neurons as the cells that form the pathways used to send information through the brain. One neuron can release a chemical messenger, called a neurotransmitter, into the narrow space between cells. The messenger can attach to a receptor on the receiving cell and change what that cell does. NIDA describes transporters as molecules that can return some messengers to the cell they came from, which limits the signal.
NIDA explains that drugs can interfere with signaling in different ways. Some can act on the receiving cell by resembling a chemical messenger. Others can cause cells to release large amounts of a messenger or interfere with its return to the cell. These are different ways the signals within a network can change. In NIDA’s explanation of the cell’s response, the fit between a messenger and its receptor helps determine where the signal goes. That gives some chemical signals a more specific destination than the narrow space between the cells might suggest. A brain circuit is a set of connected cells that work together on functions such as learning, responding to stress, or making decisions.
Reward, dopamine, and learning
NIDA describes dopamine as one of the messengers used in the brain's reward circuit. The circuit is active in ordinary experiences, such as sharing time with other people or enjoying a meal. In NIDA's account, a burst of dopamine helps the brain register what was important about an experience. It can strengthen connections involved in repeating a behavior. This learning process is called reinforcement, and it is part of how routines become familiar.
NIDA distinguishes the feeling of pleasure from the reinforcement of an activity. Scientists still have questions about the chemistry of the pleasure some drugs cause. NIDA describes dopamine as playing a larger role in learning to repeat an activity associated with pleasure than in causing the feeling itself. This helps explain why the sequence of events around drug use matters along with the immediate effects of the drug.
NIDA describes how some drugs can produce larger dopamine signals than the bursts associated with ordinary rewards. The brain can learn an association between the substance, its effect, and the surroundings in which the person used it. A place or part of a routine associated with the experience is called a cue. NIDA describes how a cue can prompt craving even when the substance is absent, and how those learned associations can persist after a person has stopped using it.
Brain areas NIDA describes
Basal ganglia and reward
The basal ganglia are part of the brain's reward circuit in NIDA's account. They contribute to motivation, learning habits, and forming routines. With repeated exposure to a drug, NIDA explains that this circuit can become less sensitive. The agency connects that change with everyday activities feeling less enjoyable than they did before.
Extended amygdala and stress
NIDA associates the extended amygdala with stressful feelings such as unease, anxiety, and irritability. The agency describes this circuit as becoming more sensitive with continued drug use. In this account, as the drug effect fades, relief from discomfort can become a reason to use the substance again. That is a different kind of motivation from seeking an enjoyable feeling.
Prefrontal cortex and self-control
NIDA describes the prefrontal cortex as important for thinking ahead, solving problems, making decisions, and exercising self-control. The agency explains that when the balance between this circuit and those involved in reward and stress shifts, a person can find it harder to control the impulse to seek the substance. The prefrontal cortex also develops late compared with other parts of the brain, a subject covered further in the page on teens and substance use.
Tolerance, dependence, and withdrawal
NIDA uses the term tolerance for the change that can occur when a familiar amount of a substance has less of its earlier effect. One example in NIDA's account involves the reward circuit producing fewer chemical messengers or having fewer receptors available to receive them. Tolerance is a property of the body's response over time.
NIDA defines physical dependence in terms of cells adapting to a substance's presence after repeated exposure. The absence of the substance can bring discomfort or other reactions called withdrawal. NIDA describes possible withdrawal symptoms, including restlessness, poor sleep, and anxiety. What someone experiences depends on the substance and the person, as NIDA's discussion of dependence illustrates.
NIDA describes addiction as a pattern of seeking and using a substance that becomes hard to control even when it causes harm. This definition draws attention to behavior and consequences in addition to a person's physical response. The page on alcohol and health describes how providers consider both symptoms and their effects on daily life for alcohol use disorder. The page on person-first language explains the difference between describing a condition and making it a label for a person.
NIDA reports that brain imaging studies of people with addiction show physical changes in areas involved in judgment, learning, memory, and control of behavior. The agency uses this evidence to help explain why a person can experience substance use as compulsive. Imaging describes physical changes, while the definition of the condition describes a person's behavior and the harm they experience.
What chronic and treatable mean here
In its account of addiction, NIDA describes addiction as a chronic disorder. It describes changes in reward, stress, and self-control that can last long after a person has stopped using a substance. The learned link between a cue and drug use is one example NIDA gives of a persistent brain change. The duration can differ from changes a person feels during an episode of use or withdrawal.
NIDA describes addiction as treatable and discusses care as a way of managing its effects on the brain and behavior over time. The agency explains that a return to use can occur during recovery and can indicate a need to review the treatment plan. In NIDA's description of care, treatment also considers medical, mental health, and social needs that differ from person to person. The brain account helps explain some challenges of changing a pattern, and the page on recovery support describes support people may encounter in daily life.